Millennium Management LLC Trims Stock Holdings in Nyxoah S.A. (NASDAQ:NYXH)

Millennium Management LLC lowered its holdings in Nyxoah S.A. (NASDAQ:NYXH) by 8.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 170,811 shares of the company’s stock after selling 16,556 shares during the period. Millennium Management LLC owned about 0.50% of Nyxoah worth $1,366,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Geode Capital Management LLC grew its position in shares of Nyxoah by 19.4% in the 4th quarter. Geode Capital Management LLC now owns 17,100 shares of the company’s stock worth $137,000 after acquiring an additional 2,774 shares in the last quarter. Walleye Capital LLC grew its position in shares of Nyxoah by 23.9% in the 4th quarter. Walleye Capital LLC now owns 14,831 shares of the company’s stock worth $119,000 after acquiring an additional 2,862 shares in the last quarter. Kovack Advisors Inc. grew its position in shares of Nyxoah by 100.0% in the 4th quarter. Kovack Advisors Inc. now owns 20,000 shares of the company’s stock worth $160,000 after acquiring an additional 10,000 shares in the last quarter. LPL Financial LLC acquired a new position in shares of Nyxoah in the 4th quarter worth approximately $102,000. Finally, Ameriprise Financial Inc. acquired a new position in shares of Nyxoah in the 4th quarter worth approximately $135,000.

Analyst Ratings Changes

Several brokerages have recently commented on NYXH. HC Wainwright reiterated a “buy” rating and issued a $15.00 target price on shares of Nyxoah in a research report on Tuesday, April 8th. Stifel Nicolaus decreased their target price on Nyxoah from $15.00 to $14.00 and set a “buy” rating for the company in a research report on Monday, April 21st.

Nyxoah Trading Up 2.4%

Shares of NASDAQ NYXH opened at $7.82 on Wednesday. The company has a market cap of $266.35 million, a price-to-earnings ratio of -4.18 and a beta of 1.56. Nyxoah S.A. has a 12-month low of $5.55 and a 12-month high of $11.87. The company has a current ratio of 5.28, a quick ratio of 4.95 and a debt-to-equity ratio of 0.21. The stock’s 50 day simple moving average is $6.57 and its 200 day simple moving average is $8.47.

Nyxoah (NASDAQ:NYXH) last announced its quarterly earnings results on Wednesday, May 14th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by ($0.14). The company had revenue of $1.12 million during the quarter, compared to the consensus estimate of $1.64 million. Nyxoah had a negative return on equity of 51.68% and a negative net margin of 1,043.93%. Equities research analysts expect that Nyxoah S.A. will post -1.91 EPS for the current year.

Nyxoah Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.